Bayer Prolactin Receptor Antibody For Male And Female Pattern Hair Loss

trialAcc

Senior Member
My Regimen
Reaction score
1,531
The only thing clear is that treating hairloss is not on the top of their priorities list, as per the clinical trials they started with the focus of another disease — and probably because of the reasons you stated. The rest is us speculating.
You're the one who who was speculating, causing him to comment. For all we know, they applied for both at the same time or the Androgenetic Alopecia one first and it got rejected due to the phase 1 structure or something that the FDA/Australian government didn't like in the trial design. You're the one that said they prioritize it less, which is something we absolutely don't know.
 

werefckd

Experienced Member
My Regimen
Reaction score
595
You're the one who who was speculating, causing him to comment. For all we know, they applied for both at the same time or the Androgenetic Alopecia one first and it got rejected due to the phase 1 structure or something that the FDA/Australian government didn't like in the trial design. You're the one that said they prioritize it less, which is something we absolutely don't know.
Sure there could be corner case hypothesis, but we know where the probabilities are
 

trialAcc

Senior Member
My Regimen
Reaction score
1,531
Sure there could be corner case hypothesis, but we know where the probabilities are
No dude, what you are describing is a corner case. We have multiple press releases and direct statements from their CEO talking about how the Androgenetic Alopecia trial will be happening. Unless you seem to think that every statement they've made is somehow now false, except that hairloss is the primary indication at the moment regardless of which trial was initiated first.
 

RolfLeeBuckler

Experienced Member
My Regimen
Reaction score
984
You're the one who who was speculating, causing him to comment. For all we know, they applied for both at the same time or the Androgenetic Alopecia one first and it got rejected due to the phase 1 structure or something that the FDA/Australian government didn't like in the trial design. You're the one that said they prioritize it less, which is something we absolutely don't know.
Sorry where do we get the Information that the alopecia trial got rejected?

I think this was just speculation of us
 

werefckd

Experienced Member
My Regimen
Reaction score
595
No dude, what you are describing is a corner case. We have multiple press releases and direct statements from their CEO talking about how the Androgenetic Alopecia trial will be happening. Unless you seem to think that every statement they've made is somehow now false, except that hairloss is the primary indication at the moment regardless of which trial was initiated first.
Lol at press releases. We’re past the talk the talk stage. Let’s see if in 6 months from now they have started the clinical trials for hairloss or not.
 

trialAcc

Senior Member
My Regimen
Reaction score
1,531
Sorry where do we get the Information that the alopecia trial got rejected?

I think this was just speculation of us
I am saying it's all speculation. The only thing we know is that they said they intended to start it last year, but only started the endo one to date.
 

trialAcc

Senior Member
My Regimen
Reaction score
1,531
Lol at press releases. We’re past the talk the talk stage. Let’s see if in 6 months from now they have started the clinical trials for hairloss or not.
If they have not, something will have 100% gone wrong.
 

pegasus2

Senior Member
My Regimen
Reaction score
4,512
for someone without hair the only option wil be stemson?
Tsuji if they have donor hair. HMI-115 might also work on alopecia areata. JAK inhibitors work insanely well for people who lose hair everywhere.
 

coolio

Experienced Member
My Regimen
Reaction score
561
JAK inhibitors work insanely well for people who lose hair everywhere.

The JAK results were so disappointingly clear. It's amazing for areata loss and yet it doesn't even touch androgenic loss.
 

pegasus2

Senior Member
My Regimen
Reaction score
4,512
The JAK results were so disappointingly clear. It's amazing for areata loss and yet it doesn't even touch androgenic loss.
Well the jak inhibitor trial for Androgenetic Alopecia did show a result approximate to minoxidil, but of course that still leaves you very bald in most cases.
 

pegasus2

Senior Member
My Regimen
Reaction score
4,512
thanks for info, what is the diferrence between Tsuji and Fukuda treatment?
No idea, sorry. I'm not familiar with Fukuda. I think he's the researcher at Yokohama, but I haven't familiarized myself with them
 

pegasus2

Senior Member
My Regimen
Reaction score
4,512
The French fry guy
Ok, yeah that's Yokohama. The french fry thing makes me question their credibility. Idk if the association came from them or the media, but the chemical itself had nothing to do with Androgenetic Alopecia. They overhyped it. I hope they are not overhyping this too
 

Throwaway94

Experienced Member
My Regimen
Reaction score
614
Ok, yeah that's Yokohama. The french fry thing makes me question their credibility. Idk if the association came from them or the media, but the chemical itself had nothing to do with Androgenetic Alopecia. They overhyped it. I hope they are not overhyping this too
Meh they're using a similar approach as Stemson but in a much worse position to commercialise. Sound technology but wouldn't put much stock in them panning out for us in the timeframes we want
 

pegasus2

Senior Member
My Regimen
Reaction score
4,512
Meh they're using a similar approach as Stemson but in a much worse position to commercialise. Sound technology but wouldn't put much stock in them panning out for us in the timeframes we want
So they're using iPSCs from blood? Frankly I have more faith in Stemson to solve it if that's the case.
 
Top